Hologic (WBO:HOLX) FFO


WBO:HOLX Hologic Inc WBO:HOLX
57 GF Score
Price €65.50
GF Value €70.70
! 4 Warning Signs
View Full Analysis

What is Hologic FFO?

FFO (Funds from operations) only applies to REITs.

WBO:HOLX
57GF Score
Hologic Inc WBO:HOLX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hologic (WBO:HOLX) Overvalued in 2026?

Based on GuruFocus' analysis, Hologic stock appears to be undervalued. The current stock price of €65.50 is trading 7.4% below its estimated GF Value™ of €70.70.

Key valuation signals for WBO:HOLX:

  • FFO:
  • GF Value™: €70.70 vs. price of €65.50 (7.4% below fair value)
  • GF Score™: 57/100 with 4 warning signs

No single metric tells the full story. See the WBO:HOLX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hologic Business Description

Address 250 Campus Drive, Marlborough, MA, USA, 01752
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
57GF Score

Get the complete analysis for WBO:HOLX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€65.50
Price
€70.70
GF Value